BRGX.US BioRegenx, Inc.

Healthcare Health Information Services USA Stocks
0.0001 USD
Close of Nov 6, 2026
0.0001 0.0194
Market cap
USD 97.2K
P/E
-
P/B
1.01x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2026.

Is BRGX.US undervalued?

Graham number

The Graham number of BioRegenx, Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

BioRegenx, Inc. fundamental analysis

No fundamental analysis for BioRegenx, Inc. yet.

BioRegenx, Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About BioRegenx, Inc.

BioRegenx, Inc. engages in the research, development, and commercialization of dietary supplements, medical devices, software, and contactless diagnostic technologies in the United States and internationally. The company offers DocSun AI engine, which integrates with a ballistocardiograph that detects an individual's heartbeat; TruScan.AI mobile app for additional health indications; VitalWellness app for DNA and epigenetics platform; and Endocalyx Pro, a dietary supplement …

Full company profile